NCT05792137

Brief Summary

The purpose of this research is to determine the role of a type of immune cell in blood, called a non-classical monocytes (NCMs), following consumption of a high-fat meal. Previous studies have found that monocytes are important for blood vessel health. In this study, two different high-fat meals will be used to study the effect of different types of dietary fat on postprandial NCMs. The investigators will characterize NCMs in both fasting conditions and following consumption of two different high-fat meals, and will evaluate whether the type of fat in a meal affects NCMs in blood.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 31, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

November 14, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2024

Completed
Last Updated

March 12, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

March 15, 2023

Last Update Submit

March 7, 2025

Conditions

Keywords

monocytepostprandialnonclassical monocytes

Outcome Measures

Primary Outcomes (1)

  • Change in Monocyte subsets

    Monocyte subsets will be analyzed using flow cytometry. Subset analysis will be performed by labeling immune cells with anti-cluster of differentiation antigen 45 (anti-CD45), cluster of differentiation antigen 91 (anti-CD91), anti-CD14, and anti-CD16 fluorescently labeled antibodies.

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

Secondary Outcomes (38)

  • Change in white blood cell count

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

  • Change in lymphocyte count

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

  • Change in monocyte count

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

  • Change in change in neutrophil granulocyte count

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

  • Change in eosinophil count

    Measured from samples taken at 0 hours (fasting) and 6 hours (postprandial) on 2 test days

  • +33 more secondary outcomes

Study Arms (2)

High saturated fat challenge meal followed by high mono-unsaturated fat challenge meal

EXPERIMENTAL

High saturated fat mixed macronutrient challenge meal with palm oil followed by high mono-unsaturated fat mixed macronutrient challenge meal with olive oil two weeks later

Other: High saturated fat challenge mealOther: High mono unsaturated fat challenge meal

High mono-unsaturated fat challenge meal followed by high saturated fat challenge meal

EXPERIMENTAL

High mono-unsaturated fat mixed macronutrient challenge meal with olive oil followed by high saturated fat mixed macronutrient challenge meal with palm oil two weeks later

Other: High saturated fat challenge mealOther: High mono unsaturated fat challenge meal

Interventions

High saturated fat challenge meal made with palm oil

High mono-unsaturated fat challenge meal followed by high saturated fat challenge mealHigh saturated fat challenge meal followed by high mono-unsaturated fat challenge meal

High mono unsaturated fat challenge meal made with olive oil

High mono-unsaturated fat challenge meal followed by high saturated fat challenge mealHigh saturated fat challenge meal followed by high mono-unsaturated fat challenge meal

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 18.5 - 29.9 kg/m²
  • have a bank account and social security number or taxpayer identification for financial compensation

You may not qualify if:

  • Pregnant or lactating women
  • Known allergy or hindering intolerance to study meal ingredients
  • Systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg measured
  • Fasting glucose above 105 mg/dL
  • Triglycerides above 150 mg/dL
  • HDL cholesterol less than 40 mg/dL (men) and 50 mg/dL (women)
  • Self-reported history of difficulties with blood drawing procedures including prior fainting or dizziness, or veins assessed as not suitable for four separate venipunctures by licensed phlebotomist
  • Diagnosed active chronic diseases for which the individual is currently taking daily medication, including but not limited to Diabetes mellitus, Cardiovascular disease, Cancer, Gastrointestinal disorders, Kidney disease, Liver disease, Bleeding disorders, Asthma, Autoimmune disorders, Hypertension, Osteoporosis
  • Recent minor surgery (within 4 wk) or major surgery (within 16 wk)
  • History of gastrointestinal surgery, including gastric bypass surgery or resection
  • Recent antibiotic therapy (within 4 wk)
  • Known gallbladder disease or history of cholecystectomy
  • Recent hospitalization (within 4 wk)
  • Use of prescription medications at the time of the study that directly affect endpoints of interest (e.g. hyperlipidemia, glycemic control, steroids, statins, anti-inflammatory agents, and over-the-counter weight loss aids)
  • Current participation in another research study
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USDA Western Human Nutrition Research Center

Davis, California, 95616, United States

Location

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ryan Snodgrass, PhD

    USDA, Western Human Nutrition Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2023

First Posted

March 31, 2023

Study Start

November 14, 2023

Primary Completion

October 11, 2024

Study Completion

October 11, 2024

Last Updated

March 12, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations